SANOFINSESanofi India Limited· PharmaceuticalsMediumNeutral
Announced Wed, 25 Mar · 12:26 IST

Sanofi India Limited has informed the Exchange regarding appointment of Mr. Siraj Azmat Chaudhry as Non- Executive Independent Director of the Company w.e.f. April 01, 2026.

Management Changes View source PDF

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹3248.00
prior close
₹3324.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.1-0.0-0.1-2.7-1.3-0.1+0.4+2.6+5.3+10.3+5.5-2.1+2.9
Up moveDown movePending
AI summary

Sanofi India's board met on March 25, 2026 and approved three key items. First, the 70th Annual General Meeting will be held on April 29, 2026 via video conferencing. Second, the final dividend of Rs. 48 per equity share (face value Rs. 10) for FY ended December 31, 2025, previously recommended in February 2026, has a record date of April 22, 2026. Third, Mr. Siraj Azmat Chaudhry (DIN: 00161853), former Chairman of Cargill India, has been appointed as Additional Director and Independent Director for a 5-year term from April 1, 2026 to March 31, 2031, subject to shareholder approval. He brings over 35 years of experience in agriculture and food industry leadership and currently serves on boards of Jubilant Ingrevia, Carrier, Bikaji Foods, and Triveni Engineering.

Likely market impact

Routine corporate governance update with no negative signals — the dividend of Rs. 48/share is positive for income-seeking shareholders, and the new independent director adds experienced oversight to the board. Shareholders should watch for the April 22, 2026 record date to be eligible for the final dividend.